BiBB receives an Intention to Grant for electric-driven EndoDrill in Europe
The cancer diagnostics company BiBBInstruments AB ("BiBB or the "Company") announces that the Company has received an Intention to Grant from the European Patent Office (EPO). This means that EPO intends to approve the Company's first patent application in Europe for EndoDrill[®], the world's first CE-marked electric-driven endoscopic biopsy instrument. A few additional formal steps will follow before a final notice of approval can be issued, after which the granted patent will be valid until October 2039.BIBB has received an Intention to Grant from the EPO for its patent application EP